Adeno-associated Virus Genome Population Sequencing Achieves Full Vector Genome Resolution and Reveals Human-Vector Chimeras
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Tai, Phillip W. L.Xie, Jun
Fong, Kaiyuen
Seetin, Matthew
Heiner, Cheryl
Su, Qin
Weiand, Michael
Wilmot, Daniella
Zapp, Maria L
Gao, Guangping
UMass Chan Affiliations
Center for AIDS ResearchProgram in Molecular Medicine
Viral Vector Core
Department of Microbiology and Physiological Systems
Li Weibo Institute for Rare Diseases Research
Horae Gene Therapy Center
Document Type
Journal ArticlePublication Date
2018-06-15Keywords
AAV-GPseqgene therapy vector QC
rAAV-ITR
recombinant adeno-associated virus
single molecule real-time sequencing
Bioinformatics
Genetics and Genomics
Therapeutics
Metadata
Show full item recordAbstract
Recombinant adeno-associated virus (rAAV)-based gene therapy has entered a phase of clinical translation and commercialization. Despite this progress, vector integrity following production is often overlooked. Compromised vectors may negatively impact therapeutic efficacy and safety. Using single molecule, real-time (SMRT) sequencing, we can comprehensively profile packaged genomes as a single intact molecule and directly assess vector integrity without extensive preparation. We have exploited this methodology to profile all heterogeneic populations of self-complementary AAV genomes via bioinformatics pipelines and have coined this approach AAV-genome population sequencing (AAV-GPseq). The approach can reveal the relative distribution of truncated genomes versus full-length genomes in vector preparations. Preparations that seemingly show high genome homogeneity by gel electrophoresis are revealed to consist of less than 50% full-length species. With AAV-GPseq, we can also detect many reverse-packaged genomes that encompass sequences originating from plasmid backbone, as well as sequences from packaging and helper plasmids. Finally, we detect host-cell genomic sequences that are chimeric with inverted terminal repeat (ITR)-containing vector sequences. We show that vector populations can contain between 1.3% and 2.3% of this type of undesirable genome. These discoveries redefine quality control standards for viral vector preparations and highlight the degree of foreign products in rAAV-based therapeutic vectors.Source
Mol Ther Methods Clin Dev. 2018 June 15;9:130-141. doi: 10.1016/j.omtm.2018.02.002. eCollection 2018 Jun 15. Link to article on publisher's site
DOI
10.1016/j.omtm.2018.02.002Permanent Link to this Item
http://hdl.handle.net/20.500.14038/40693PubMed ID
29766023Related Resources
Rights
Copyright © 2018 The Author(s). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Distribution License
http://creativecommons.org/licenses/by-nc-nd/4.0/ae974a485f413a2113503eed53cd6c53
10.1016/j.omtm.2018.02.002
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © 2018 The Author(s). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).